Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence

Alcohol

Volumn 29, Issue 2, 2003, Pages 55-60

  Valdez, Glenn R ^a   Zorrilla, Eric P ^a   Roberts, Amanda J ^a   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CRF; Elevated plus maze; Ethanol; Protracted abstinence; Rat; Stress

Indexed keywords

ALCOHOL; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CANNULA; CONTROLLED STUDY; HORMONAL REGULATION; HORMONE DETERMINATION; HORMONE INHIBITION; IMMOBILIZATION STRESS; LATERAL BRAIN VENTRICLE; MALE; MAZE TEST; MICROINJECTION; NONHUMAN; RAT; REGULATORY MECHANISM; SURGICAL TECHNIQUE;

ANIMALIA;

EID: 0038022706     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-8329(03)00020-X     Document Type: Article

References (38)

1. Andrews N., File S.E. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. Eur J Pharmacol. 235:1993;109-112.
2. Annis H.M., Sklar S.M., Moser A.E. Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics. Addict Behav. 23:1998;127-131.
3. Baldwin H.A., Rassnick S., Rivier J., Koob G.F., Britton K.T. CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berl). 103:1991;227-232.
4. Begleiter H., Porjesz B. Persistence of a "subacute withdrawal syndrome" following chronic ethanol intake. Drug Alcohol Depend. 4:1979;353-357.
5. Britton K.T., Lee G., Dana R., Risch S.C., Koob G.F. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci. 39:1986;1281-1286.
6. Cloninger C.R. Neurogenetic adaptive mechanisms in alcoholism. Science. 236:1987;410-416.
7. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav. 49:1994;171-176.
8. De Soto C.B., O'Donnell W.E., Allred L.J., Lopes C.E. Symptomatology in alcoholics at various stages of abstinence. Alcohol Clin Exp Res. 9:1985;505-512.
9. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev. 15:1990;71-100.
10. Ehlers C.L., Chaplin R.I. Chronic ethanol exposure potentiates the locomotor-activating effects of corticotropin-releasing factor (CRF) in rats. Regul Pept. 19:1987;345-353.
11. Grant I., Reed R., Adams K.M. Diagnosis of intermediate-duration and subacute organic mental disorders in abstinent alcoholics. J Clin Psychiatry. 48:1987;319-323.
12. Heinrichs S.C., Menzaghi F., Pich E.M., Baldwin H.A., Rassnick S., Britton K.T., Koob G.F. Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity. Neuropsychopharmacology. 11:1994;179-186.
13. Hershon H.I. Alcohol withdrawal symptoms and drinking behavior. J Stud Alcohol. 38:1977;953-971.
14. Hölter S.M., Engelmann M., Kirschke C., Liebsch G., Landgraf R., Spanagel R. Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats. Behav Pharmacol. 9:1998;41-48.
15. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. (1996) Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press.
16. Koob G.F. Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry. 46:1999;1167-1180.
17. Koob G.F., Heinrichs S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 848:1999;141-152.
18. Koob G.F., Heinrichs S.C., Menzaghi F., Pich E.M., Britton K.T. Corticotropin releasing factor, stress, and behavior. Semin Neurosci. 6:1994;221-229.
19. Koob G.F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 278:1997;52-58.
20. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 24:2001;97-129.
21. Menzaghi F., Howard R.L., Heinrichs S.C., Vale W., Rivier J., Koob G.F. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J Pharmacol Exp Ther. 269:1994;564-572.
22. Merlo-Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., Weiss F. Increase of extracellular corticotropin-releasing factor like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci. 15:1995;5439-5447.
23. Möller C., Wiklund L., Sommer W., Thorsell A., Heilig M. Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res. 760:1997;94-101.
24. Mormede P., Razafimanalina N., Courvoisier H., Ramos A., Berton O., Chaouloff F. QTLs for temperament traits in rats: relevance for alcohol drinking. (Abstract) Alcohol Clin Exp Res. 22:(Suppl):1998;151A.
25. Pellegrino L.J., Pellegrino A.S., Cushman A.J. A Stereotaxic Atlas of the Rat Brain. 1979;Plenum Press, New York.
26. Pollard G.T., Howard J.L. Effects of drugs on punished behavior: pre-clinical test for anxiolytics. Pharmacol Ther. 45:1990;403-424.
27. Rasmussen D.D., Mitton D.R., Green J., Puchalski S. Chronic daily ethanol and withdrawal: 2. behavioral changes during prolonged abstinence. Alcohol Clin Exp Res. 25:2001;999-1005.
28. Rassnick S., Heinrichs S.C., Britton K.T., Koob G.F. Micro-injection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605:1993;25-32.
29. Richter R.M., Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse. 32:1999;254-261.
30. Roelofs S.M. Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome. Alcohol. 2:1985;501-505.
31. Schulteis G., Hyytia P., Heinrichs S.C., Koob G.F. Effects of chronic ethanol exposure on oral self-administration of ethanol or saccharin by Wistar rats. Alcohol Clin Exp Res. 20:1996;164-171.
32. Slawecki C.J., Somes C., Ehlers C.L. Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y. Alcohol Alcohol. 34:1999;289-299.
33. Spina M.G., Basso A.M., Zorrilla E.P., Heyser C.J., Rivier J., Vale W., Merlo-Pich E., Koob G.F. Behavioral effects of central administration of the novel CRF antagonist astressin in rats. Neuropsychopharmacology. 22:2000;230-239.
34. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., Koob G.F. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res. 26:2002;1494-1501.
35. Vale W., Rivier C., Brown M.R., Spiess J., Koob G., Swanson L., Bilezikjian L., Bloom F., Rivier J. Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res. 39:1983;245-270.
36. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1981;1394-1397.
37. Zorrilla E.P., Valdez G.R., Nozulak J., Koob G.F., Markou A. Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res. 952:2002;188-199.
38. Zorrilla E.P., Valdez G.R., Weiss F. Changes in levels of regional CRF-like immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl). 158:2001;374-381.